Delaware's spending on weight loss drugs continues to skyrocket

Delaware's spending on weight loss drugs continues to skyrocket

Why Should Delaware Care?Delaware began to cover commercial weight-loss drugs like Ozempic and Wegovy for state employees in 2023 as part of the state health plan. Now, claims for the drug have skyrocketed, and taxpayers are footing the bill.  Delaware state workers’ increasing use of blockbuster weight-loss drugs is weighing heavily on the state’s budget.  The state will likely spend more than $134 million on drugs Ozempic and Wegovy for state …